Training Program in Cancer Biology
Training Program in Cancer Biology
批准号:
9404559
负责人:
Scott D Cramer
金额:
$0.54万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-07 至 2021-06-30
中文摘要
摘要
尽管在过去的几年里,我们对细胞和分子的基本理解取得了重大突破,
导致癌症的变化,致癌过程中的许多关键步骤,以及早期癌症的变化,
侵袭和转移,仍然定义不清。严格培训未来的年轻癌症研究人员
生物学将是必不可少的,在我们寻求更深入地了解致癌作用,并为发展,
更好的早期癌症检测方法,更好的诊断和有效的新癌症治疗方法。的
癌症生物学培训计划(TPCB)是一个跨所有癌症亚型的多学科计划,
利用CU Anschutz的独特优势和培训机会,包括世界知名的研究
在功能基因组学,实验治疗,类固醇受体信号,干细胞和器官特异性
癌症(特别是肺癌、乳腺癌、前列腺癌和血癌)。我们的目标是提供跨学科的培训,
癌症研究的前沿,以最好地准备我们的学员在生物医学研究环境中竞争
越来越注重基础研究的转化应用。我们的培训计划包括实验室
培训、教学活动、参加科学会议、职业发展和职业生涯
指导,沟通技巧的发展,并接触到临床的角度。这个项目的合作伙伴
培训计划在整合科罗拉多癌症大学的机构内发挥领导作用
中心和研究生院加入这个培训计划。克莱默博士是荷尔蒙相关的联合主任
癌症中心内的癌症小组,并与其他癌症中心领导层合作,
和癌症中心的方向。Reyland博士是癌症生物学博士前培训项目的主任,
与研究生院有着紧密的联系。额外的整合来自其他培训教师谁是
癌症中心的所有成员(许多人担任领导角色),其中一些人还在癌症中心担任领导角色。
研究生院来自癌症中心,研究生院和各个部门的资源是
致力于支持培训计划。癌症中心的基础设施尤为重要,
它为培训学院提供核心资源,因此受训人员也可以利用这些资源。的
拟议的计划将包括通过癌症生物学研究生培训计划进行博士前培训,
它设在研究生院,并为博士提供博士后培训。31名培训教师
是根据他们的科学专长和指导记录而选出的。基于国家信息中心
博士后/博士前培养比例为3:1,本次申请拟聘任新博士后3名,新博士1名
第一年为博士预科生,第二至第五年为每奖年6名博士后和2名博士预科生。我们
将根据学员的研究和学术记录,从外部和内部人才库中挑选学员,
致力于癌症研究。我们致力于在各级提供全面的培训,
最好的准备我们的学员在学术界内外的生物医学科学的成功职业生涯。
英文摘要
ABSTRACT
Despite major breakthroughs over the past few years in our basic understanding of the cellular and molecular
changes that lead to cancer, many key steps in carcinogenesis, and changes in early cancers that promote
invasion and metastasis, still remain poorly defined. Rigorous training of future young investigators in cancer
biology will be essential in our quest for a deeper understanding of carcinogenesis, and for the development of
better methods of early cancer detection, improved diagnosis, and effective new cancer treatments. The
Training Program in Cancer Biology (TPCB) is a multidisciplinary program across all cancer subtypes that
capitalizes on the unique strengths and training opportunities at CU Anschutz including world renown research
in functional genomics, experimental therapeutics, steroid receptor signaling, stem cells and organ specific
cancers (in particular lung, breast, prostate and blood). Our goal is to provide interdisciplinary training at the
cutting edge of cancer research to best prepare our trainees to compete in a biomedical research environment
increasingly focused on translational applications of basic research. Our training plan consists of laboratory
training, didactic activities, attendance at scientific conferences, professional development and career
mentoring, development of communication skills, and exposure to the clinical perspective. The Co-PIs of this
training program have leadership roles within the institution that integrate the University of Colorado Cancer
Center and the Graduate School into this training program. Dr. Cramer is co-director of the Hormone-Related
Malignancies group within the Cancer Center and works with other Cancer Center leadership to establish goals
and directions of the cancer center. Dr. Reyland is director of the Cancer Biology pre-doctoral training program,
providing a strong link to the Graduate School. Additional integration comes from other training faculty who are
all members of the Cancer Center (many with leadership roles), and several also have leadership roles in the
Graduate School. Resources from the Cancer Center, the Graduate School, and individual departments are
committed to support the training program. The infrastructure of the Cancer Center is particularly important as
it provides core resources available to training faculty that are therefore available to the trainees. The
proposed program will include pre-doctoral training through the graduate training program in Cancer Biology,
which is housed in the Graduate School, and post-doctoral training for PhDs. The total of 31 training faculty
were selected based on their scientific expertise and track record of mentorship. Based on the NCIs
postdoctoral/predoctoral training ratio of 3:1, this application proposes to appoint 3 new postdocs and 1 new
predoctoral student in year 1, and 6 post-docs and 2 pre-doctoral students per award year for years 2-5. We
will select trainees from external and internal pools based on their research and academic records and
commitment to cancer research. We are committed to providing comprehensive training at all levels so as to
best prepare our trainees for successful careers in biomedical science inside or outside academia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10657393
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10276486
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10439892
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:10332080
-
项目类别:
-
资助金额:$25.18万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Autophagy regulation of prostate tumor development
-
批准号:9096644
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:9312767
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:10670055
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
-
批准号:9265055
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and TAK1 Synthetic Lethality in Prostate Cancer
-
批准号:8873686
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
-
批准号:9090060
-
项目类别:
-
资助金额:$38.87万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and TAK1 Synthetic Lethality in Prostate Cancer
-
批准号:9047256
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
Isolation of Tumor Initiating Cells (TICs) using Contactless Dielectrophoresis
-
批准号:8547799
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2012
-
负责人:Scott D Cramer
-
依托单位:
Isolation of Tumor Initiating Cells (TICs) using Contactless Dielectrophoresis
-
批准号:8431874
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2012
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8676711
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8326107
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8469833
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8105199
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:8053797
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:7828004
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:8316493
-
项目类别:
-
资助金额:$21.24万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
海外基金